Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (281-290 of 755) with videos related to

Pageof 76
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1982
Relationship of serum naproxen concentration to efficacy in rheumatoid arthritisR O Day, D E Furst, S H Dromgoole, et al.
Radiology|August 1, 1988
Seronegative and seropositive rheumatoid arthritis: radiographic differencesG Y el-Khoury, R K Larson, M H Kathol, et al.
Blood|March 9, 1999
Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with sclerodermaP C Evans, N Lambert, S Maloney, et al.
Arthritis and Rheumatism|January 1, 1994
Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followupP J Clements, P A Lachenbruch, D E Furst, et al.
Lancet (London, England)|January 24, 2012
Haemopoietic stem-cell transplantation for systemic sclerosisKeith M Sullivan, Frederick M Wigley, Christopher P Denton, et al.
Clinical Rheumatology|February 27, 2017
Misalignment between physicians and patient satisfaction with psoriatic arthritis disease controlDaniel E Furst, Melody Tran, Emma Sullivan, et al.
The Journal of Rheumatology. Supplement|May 1, 1997
Autologous stem cell transplantation for autoimmune diseases: issues in protocol developmentP A McSweeney, R A Nash, R Storb, et al.
Seminars in Cutaneous Medicine and Surgery|July 27, 2017
Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminar™Kenneth B Gordon, Craig L Leonardi, Daniel E Furst, et al.
The Journal of Rheumatology|December 7, 2005
Scleroderma--developing measures of responseDaniel E Furst, Dinesh Khanna, Marco Mattucci-Cerinic, et al.
Rheumatology and Therapy|September 6, 2021
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid ArthritisElizabeth A Holdsworth, Bethany Donaghy, Kathleen M Fox, et al.
Pageof 76

Showing results (281-290 of 755) with videos related to

Sort By:
Pageof 76
Clinical Pharmacology and Therapeutics|June 1, 1982
Relationship of serum naproxen concentration to efficacy in rheumatoid arthritisR O Day, D E Furst, S H Dromgoole, et al.
Radiology|August 1, 1988
Seronegative and seropositive rheumatoid arthritis: radiographic differencesG Y el-Khoury, R K Larson, M H Kathol, et al.
Blood|March 9, 1999
Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with sclerodermaP C Evans, N Lambert, S Maloney, et al.
Arthritis and Rheumatism|January 1, 1994
Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followupP J Clements, P A Lachenbruch, D E Furst, et al.
Lancet (London, England)|January 24, 2012
Haemopoietic stem-cell transplantation for systemic sclerosisKeith M Sullivan, Frederick M Wigley, Christopher P Denton, et al.
Clinical Rheumatology|February 27, 2017
Misalignment between physicians and patient satisfaction with psoriatic arthritis disease controlDaniel E Furst, Melody Tran, Emma Sullivan, et al.
The Journal of Rheumatology. Supplement|May 1, 1997
Autologous stem cell transplantation for autoimmune diseases: issues in protocol developmentP A McSweeney, R A Nash, R Storb, et al.
Seminars in Cutaneous Medicine and Surgery|July 27, 2017
Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminar™Kenneth B Gordon, Craig L Leonardi, Daniel E Furst, et al.
The Journal of Rheumatology|December 7, 2005
Scleroderma--developing measures of responseDaniel E Furst, Dinesh Khanna, Marco Mattucci-Cerinic, et al.
Rheumatology and Therapy|September 6, 2021
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid ArthritisElizabeth A Holdsworth, Bethany Donaghy, Kathleen M Fox, et al.
Pageof 76